Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression

Harrington, 2001, Gene therapy for prostate cancer: current status and future prospects, J. Urol., 166, 1220, 10.1016/S0022-5347(05)65742-4 Pernar, 2018, The epidemiology of prostate cancer, Cold Spring Harbor Perspect. Med., a030361 Sebesta, 2018, The surgical management of prostate cancer, Semin. Oncol., 44, 347, 10.1053/j.seminoncol.2018.01.003 Bolla, 1999, Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy—a phase III EORTC study, Eur. J. Cancer, 35, 147 Copp, 2005, Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer, Urology, 65, 1146, 10.1016/j.urology.2004.12.014 Souhami, 2009, Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31, J. Clin. Oncol., 27, 2137, 10.1200/JCO.2008.17.4052 Tang, 2008, Traditional Chinese medicine, Lancet, 372, 1938, 10.1016/S0140-6736(08)61354-9 Dondorp, 2009, Artemisinin resistance in Plasmodium falciparum malaria, N. Engl. J. Med., 361, 455, 10.1056/NEJMoa0808859 Neill, 2011, From branch to bedside: Youyou Tu is awarded the 2011 Lasker~DeBakey Clinical Medical Research Award for discovering artemisinin as a treatment for malaria, J. Clin. Invest., 121, 3768, 10.1172/JCI60887 Danbolt, 2001, Glutamate uptake, Prog. Neurobiol., 65, 1, 10.1016/S0301-0082(00)00067-8 Schultz, 1999, Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity, J. Med. Chem., 42, 2909, 10.1021/jm9900570 Zhang, 2012, Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo, Biochem. Pharmacol., 83, 1278, 10.1016/j.bcp.2012.02.002 Cui, 2012, Mechanisms of in vitro resistance to dihydroartemisinin in plasmodium falciparum, Mol. Microbiol., 86, 111, 10.1111/j.1365-2958.2012.08180.x Pashynska, 2004, Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and Fe(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry, J. Am. Soc. Mass Spectrom., 15, 1181, 10.1016/j.jasms.2004.04.030 Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734 Hsu, 2008, Cancer cell metabolism: Warburg and beyond, Cell, 134, 703, 10.1016/j.cell.2008.08.021 Pavlides, 2010, Transcriptional evidence for the “reverse Warburg effect” in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer’s disease, and “neuron-glia metabolic coupling”, Aging, 2, 185, 10.18632/aging.100134 Sotgia, 2012, Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue, Cell Cycle, 11, 1445, 10.4161/cc.19841 Lavallée, 2018, Increased prostate cancer glucose metabolism detected by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in localised Gleason 8–10 prostate cancers identifies very high-risk patients for early recurrence and resistance to castration, European Urology Focus Ross, 1999, Androgen metabolism and prostate Cancer: establishing a model of genetic susceptibility, Eur.Urol., 35, 355, 10.1159/000019909 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 Twentyman, 1987, A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity, Br. J. Cancer, 56, 279, 10.1038/bjc.1987.190 Dondorp, 2005, Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, 366, 717, 10.1016/S0140-6736(05)67176-0 Fu, 2009, Estimating accuracy of RNA-Seq and microarrays with proteomics, BMC Genomics, 10, 161, 10.1186/1471-2164-10-161 Liu, 2008, MicroRNA expression profiling using microarrays, Nat. Protoc., 3, 563, 10.1038/nprot.2008.14 Yin, 2008, Profiling microRNA expression with microarrays, Trends Biotechnol., 26, 70, 10.1016/j.tibtech.2007.11.007 Hirao, 2000, DNA damage-induced activation of p53 by the checkpoint kinase Chk2, Science, 287, 1824, 10.1126/science.287.5459.1824 Ganapathy-Kanniappan, 2013, Tumor glycolysis as a target for cancer therapy: progress and prospects, Mol. Cancer, 12, 152, 10.1186/1476-4598-12-152 Liu, 2015, Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes, Clin. Sci., 129, 839, 10.1042/CS20150009 Byrne, 2014, Metabolic vulnerabilities in endometrial cancer, Cancer Res., 74, 5832, 10.1158/0008-5472.CAN-14-0254 Sylvia, 2012, GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers, BMC Cancer, 12, 586, 10.1186/1471-2407-12-586 Sun, 2018, Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect, Biochim. Biophys. Acta, Rev. Cancer, 1870, 51, 10.1016/j.bbcan.2018.06.005 Vlassenko, 2018, Aerobic glycolysis and tau deposition in preclinical Alzheimer disease, Neurobiol. Aging, 10.1016/j.neurobiolaging.2018.03.014 Kim, 2014, Identification of noninvasive biomarkers for nephrotoxicity using HK-2 human kidney epithelial cells, Toxicol. Sci., 140, 247, 10.1093/toxsci/kfu096 Wang, 2016, Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway, Oncotarget, 7, 20193, 10.18632/oncotarget.7935 Hennessy, 2005, Exploiting the PI3K/AKT pathway for cancer drug discovery, Nat. Rev. Drug Discov., 4, 988, 10.1038/nrd1902 Ye, 2012, Sevoflurane postconditioning involves an up-regulation of HIF-1α and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia, Brain Res., 1463, 63, 10.1016/j.brainres.2012.04.050